How big is the Travel Vaccines Market?

The Travel Vaccines Market size is expected to reach USD 5 billion in 2024 and grow at a CAGR of 8.33% to reach USD 7.47 billion by 2029. Read More

What is the current Travel Vaccines Market size?

In 2024, the Travel Vaccines Market size is expected to reach USD 5 billion. Read More

Who are the key players in Travel Vaccines Market?

Abbott Laboratories, AstraZeneca plc, GSK plc, Pfizer Inc and Valneva SE are the major companies operating in the Travel Vaccines Market. Read More

Which is the fastest growing region in Travel Vaccines Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Travel Vaccines Market?

In 2024, the North America accounts for the largest market share in Travel Vaccines Market. Read More

What years does this Travel Vaccines Market cover, and what was the market size in 2023?

In 2023, the Travel Vaccines Market size was estimated at USD 4.58 billion. The report covers the Travel Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Travel Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Travel Vaccines Market Share

Statistics for the 2023 & 2024 Travel Vaccines market share, created by Mordor Intelligence™ Industry Reports. Travel Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Travel Vaccines Industry

The travel vaccines market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market share and are well known, including Abbott Laboratories, AstraZeneca plc, CSL Ltd, F. Hoffmann-La Roche AG, GSK PLC, Janssen Pharmaceuticals, Pfizer Inc, Qiagen NV, Sanofi SA, and Valneva SE.